Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.38050.593634.63 (Published 22 April 2004) Cite this as: BMJ 2004;328:983
All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
kim et al have raised important issues regarding cutoff values of
transaminases.1 what is not clear is if data such as alcohol consumption
were updated continuously
as changing consumption patterns would skew the net result resulting in
bias. transaminase data would seem to be intial data on entry into the
study which would be difficult to correlate with mortality at the end of
the study from liver diseases. it would have indeed been useful to have
identified actual liver pathology which could have provided more meaning
to observed differences in transaminase levels. this study is relevent in
the context of the emerging epidemic of non alcoholic steato
hepatitis(NASH) as lowering the upper limit of transaminase levels might
translate into a large increase in the absolute numbers of patients who
would require evaluation for an uncertain clinical benefit owing to the
detection of mild abnormalities.2
references
1.Hyeon Chang Kim, Chung Mo Nam, Sun Ha Jee, Kwang Hyub Han, Dae Kyu
Oh, and Il Suh
Normal serum aminotransferase concentration and risk of mortality from
liver diseases: prospective cohort study
BMJ 2004; 328: 983-0.
2.Kaplan, MM. Alanine aminotransferase levels: What's normal?
(editorial). Ann Intern Med 2002; 137:50.
Competing interests:
None declared
Competing interests: No competing interests
‘Normal’ serum aminotransferase concentrations?
Editor – Kim and co-workers (1) have investigated and suggested
reference limits for aminotransferase concentrations and mortality from
liver disease. However, for health derived reference limits to be used
there must be a high degree of analytical and population group
transferability (2). It would therefore be essential to report on the
analytical methods employed when commenting on specific results as per the
STARD (Standards for Reporting of Diagnostic Accuracy) initiative which
was co-published by this journal (3). Due to the lack of assay
standardization (2, 4) and therefore non-comparability, comparing absolute
values (e.g. 40 IU/L) may be misleading and confusing. For example, three
different ALT assays harmonised to the International Federation of
Clinical Chemistry method and routinely employed by accredited
laboratories have significantly different reference intervals: 21–72 IU/L
for the Vitros 250® (Ortho Diagnostics, www.orthoclinical.com), <_45 iu="iu" l="l" for="for" the="the" au640="au640" olympus="olympus" diagnostics="diagnostics" www.olympusamerica.com="www.olympusamerica.com" dsg_section="dsg_section" dsg_chemistrysys.asp="dsg_chemistrysys.asp" and="and" _3065="_3065" dimension="dimension" rxl="rxl" dade="dade" behring.="behring." furthermore="furthermore" reference="reference" intervals="intervals" differ="differ" two="two" different="different" enzymes="enzymes" ast="ast" alt="alt" _2="_2" therefore="therefore" use="use" of="of" a="a" common="common" single="single" upper="upper" limit="limit" _1="_1" is="is" discouraged.="discouraged." p="p"/> The biological variation for ALT is approximately 25%. Taking the ALT
concentration at the suggested (1) upper reference limit of 40 IU/L, the
95% confidence interval of a single estimate would be 20–60 IU/L. This
would render the utilisation of a population cut-off for ALT as
impractical for routine clinical practice when investigating individuals
with single serum estimations. It would also be important to report on,
and control for, other factors such as body mass index (lower range in the
Far East), viral hepatitis (higher incidence in the Far East), age,
gender, recent exercise, muscle injury and haemolysis as such issues may
significantly influence aminotransferase values (4).
It needs to be emphasized that if the upper normal limit is taken at
40 IU/L, 97.5% of values would be equal to or below this, but this would
only be equal to two SD above the mean if the distribution was Gaussian.
The distribution of aminotransferases show positive skewness and would
require transformation before one can state that the upper normal limit is
two SD above the mean level (5).
References:
1. Kim HC, Nam CM, Jee SH, Han KH, Oh DY, Suh I. Normal serum
aminotransferase concentration and risk of mortality from liver disease:
prospective cohort study. BMJ 2004; 328:983-86
2. Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry. 3rd
edition. WB Saunders: Philadelphia; 1999.
3. Patrick M. Bossuyt, Johannes B. Reitsma, David E. Bruns, Constantine A.
Gatsonis, Paul P. Glasziou, Les M. Irwig, et al. Towards complete and
accurate reporting of studies of diagnostic accuracy: the STARD
initiative. BMJ 2003; 326:41-44.
4. National Academy of Clinical Biochemistry. D. Robert Dufour, John A.
Lott, Frederick S. Nolte, David R. Gretch, Raymond S. Koff, and Leonard B.
Seeff
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics
of Laboratory Tests. Clin. Chem. 2000; 46:2027-2049.
5. Roderick P. Commentary: Liver function tests: defining what’s normal.
BMJ 2004; 328:987.
Competing interests:
None declared
Competing interests: No competing interests